Premium
Do They Know Something We Don't? Endorsements from Foreign MNCs and Domestic Network Advantages for Start‐Ups
Author(s) -
Aharonson Barak S.,
Tzabbar Daniel,
Amburgey Terry L.
Publication year - 2016
Publication title -
global strategy journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.814
H-Index - 24
eISSN - 2042-5805
pISSN - 2042-5791
DOI - 10.1002/gsj.1109
Subject(s) - multinational corporation , alliance , centrality , attractiveness , business , variety (cybernetics) , argument (complex analysis) , globalization , international trade , position (finance) , marketing , political science , economics , market economy , biology , psychology , biochemistry , mathematics , finance , combinatorics , artificial intelligence , computer science , psychoanalysis , law
Plain language summary This article examines the effects of alliances with foreign multinational corporations ( MNCs ) on a local start‐up's attractiveness as a partner in its domestic research networks. We argue that such international strategic alliances enhance a start‐up's subsequent alliance activity and its status in its domestic R&D network. The analysis shows that, indeed, alliances with foreign MNCs significantly enhance the start‐up's attractiveness and its future alliance activity, especially when the start‐up is young (up to the age of five). Furthermore, alliances with foreign MNCs from a variety of different countries of origin (e.g., U . K ., G ermany, and F rance) have stronger effects on a start‐up's subsequent alliance activity, supporting the argument that even in the age of globalization, location still matters. Technical summary This article examines the effects of endorsements from foreign multinational corporations ( MNCs ) on the centrality of biotech start‐ups within their domestic research networks. We argue that international strategic alliances enhance a start‐up's subsequent movement toward a more central position in its domestic R&D network. Analyzing U . S . biotech start‐ups over time, our findings show that endorsements from foreign MNCs significantly enhance the subsequent network centrality of U . S . biotech start‐ups. This endorsement effect is magnified in the early stages of the start‐up's life cycle. Furthermore, endorsements by foreign MNCs from a variety of different countries of origin have stronger effects on a start‐up's subsequent network centrality, supporting the contention that even in the age of globalization, location still matters. Copyright © 2016 Strategic Management Society.